Clinical Trial

Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
In this 24-week, single center, randomized, double-blind, placebo-controlled study, the efficacy and safety of lyophilised oral fecal microbiota transplantation in patients with active refractory rheumatoid arthritis will be evaluated.
Trial Details
NCT Number NCT07639177
Lead Sponsor Peking Union Medical College Hospital
Collaborators: Qingdao Haier Biotech Co., LTD
Conditions Rheumatoid Arthritis
Enrollment 40 participants
Start Date 2026-06-15
Primary Completion 2028-06-01 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-10